Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Lou

Showing results (311-320 of 324) with videos related to

Pageof 33
Sort By:
Science (New York, N.Y.)|March 12, 2026
Strong and brittle lithium dendritesQing Ai, Boyu Zhang, Xing Liu, et al.
Thrombosis Research|May 6, 2021
Coagulation profile in newly diagnosed T-cell acute lymphoblastic leukemiaXue-Ying Li, Yi-Le Zhou, Yi Zhang, et al.
Ebiomedicine|August 20, 2015
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic TrioxideYang Shen, Ya-Kai Fu, Yong-Mei Zhu, et al.
Nature Communications|December 31, 2024
High-performance 2D electronic devices enabled by strong and tough two-dimensional polymer with ultra-low dielectric constantQiyi Fang, Kongyang Yi, Tianshu Zhai, et al.
Science Advances|May 17, 2019
High-K dielectric sulfur-selenium alloysSandhya Susarla, Thierry Tsafack, Peter Samora Owuor, et al.
Leukemia & Lymphoma|September 16, 2015
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasmsXing-Nong Ye, Xin-Ping Zhou, Ju-Ying Wei, et al.
Journal of Hematology & Oncology|October 18, 2022
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemiaYa-Fang Ma, Ying Lu, Qian Wu, et al.
Cancer Medicine|June 4, 2020
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort studyJie-Jing Qian, Xiaoxia Hu, Ying Wang, et al.
Nature Communications|March 8, 2024
Area-selective atomic layer deposition on 2D monolayer lateral superlatticesJeongwon Park, Seung Jae Kwak, Sumin Kang, et al.
The Lancet. Oncology|May 14, 2013
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trialJie Jin, Jian-Xiang Wang, Fei-Fei Chen, et al.
Pageof 33

Showing results (311-320 of 324) with videos related to

Sort By:
Pageof 33
Science (New York, N.Y.)|March 12, 2026
Strong and brittle lithium dendritesQing Ai, Boyu Zhang, Xing Liu, et al.
Thrombosis Research|May 6, 2021
Coagulation profile in newly diagnosed T-cell acute lymphoblastic leukemiaXue-Ying Li, Yi-Le Zhou, Yi Zhang, et al.
Ebiomedicine|August 20, 2015
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic TrioxideYang Shen, Ya-Kai Fu, Yong-Mei Zhu, et al.
Nature Communications|December 31, 2024
High-performance 2D electronic devices enabled by strong and tough two-dimensional polymer with ultra-low dielectric constantQiyi Fang, Kongyang Yi, Tianshu Zhai, et al.
Science Advances|May 17, 2019
High-K dielectric sulfur-selenium alloysSandhya Susarla, Thierry Tsafack, Peter Samora Owuor, et al.
Leukemia & Lymphoma|September 16, 2015
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasmsXing-Nong Ye, Xin-Ping Zhou, Ju-Ying Wei, et al.
Journal of Hematology & Oncology|October 18, 2022
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemiaYa-Fang Ma, Ying Lu, Qian Wu, et al.
Cancer Medicine|June 4, 2020
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort studyJie-Jing Qian, Xiaoxia Hu, Ying Wang, et al.
Nature Communications|March 8, 2024
Area-selective atomic layer deposition on 2D monolayer lateral superlatticesJeongwon Park, Seung Jae Kwak, Sumin Kang, et al.
The Lancet. Oncology|May 14, 2013
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trialJie Jin, Jian-Xiang Wang, Fei-Fei Chen, et al.
Pageof 33